1. Home
  2. GBIO vs EUDA Comparison

GBIO vs EUDA Comparison

Compare GBIO & EUDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • EUDA
  • Stock Information
  • Founded
  • GBIO 2016
  • EUDA 2021
  • Country
  • GBIO United States
  • EUDA Singapore
  • Employees
  • GBIO N/A
  • EUDA N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • EUDA Blank Checks
  • Sector
  • GBIO Health Care
  • EUDA Finance
  • Exchange
  • GBIO Nasdaq
  • EUDA Nasdaq
  • Market Cap
  • GBIO 145.5M
  • EUDA 159.1M
  • IPO Year
  • GBIO 2020
  • EUDA N/A
  • Fundamental
  • Price
  • GBIO $2.17
  • EUDA $3.22
  • Analyst Decision
  • GBIO Buy
  • EUDA
  • Analyst Count
  • GBIO 4
  • EUDA 0
  • Target Price
  • GBIO $7.50
  • EUDA N/A
  • AVG Volume (30 Days)
  • GBIO 61.6K
  • EUDA 59.3K
  • Earning Date
  • GBIO 08-07-2024
  • EUDA 09-17-2024
  • Dividend Yield
  • GBIO N/A
  • EUDA N/A
  • EPS Growth
  • GBIO N/A
  • EUDA N/A
  • EPS
  • GBIO N/A
  • EUDA N/A
  • Revenue
  • GBIO $13,174,000.00
  • EUDA $3,706,458.00
  • Revenue This Year
  • GBIO $99.36
  • EUDA N/A
  • Revenue Next Year
  • GBIO N/A
  • EUDA N/A
  • P/E Ratio
  • GBIO N/A
  • EUDA N/A
  • Revenue Growth
  • GBIO 1397.05
  • EUDA N/A
  • 52 Week Low
  • GBIO $0.86
  • EUDA $0.60
  • 52 Week High
  • GBIO $4.83
  • EUDA $4.97
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 38.49
  • EUDA 35.16
  • Support Level
  • GBIO $2.26
  • EUDA $2.92
  • Resistance Level
  • GBIO $2.49
  • EUDA $4.96
  • Average True Range (ATR)
  • GBIO 0.22
  • EUDA 0.38
  • MACD
  • GBIO -0.04
  • EUDA -0.21
  • Stochastic Oscillator
  • GBIO 4.94
  • EUDA 14.63

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About EUDA EUDA Health Holdings Limited

EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.

Share on Social Networks: